Pancreatic cancer, Secondary cancers
Results
Phase 3
This trial looked at pegilodecakin (AM0010) for cancer of the pancreas that had spread ().
It was for people with advanced pancreatic cancer that continued to grow during or after having gemcitabine chemotherapy.
People could join the trial between 2017 and 2019. The team published the results in 2021.
There is a link to more information in the ‘Summary of results’ section below.
Recruitment start: 1 March 2017
Recruitment end: 9 September 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Pippa Corrie
ARMO BioSciences
Last reviewed: 09 Oct 2026
CRUK internal database number: 15405
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
